Template:Gabapentin: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8..." |
No edit summary |
||
Line 36: | Line 36: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[NEURONTIN (gabapentin) capsule , NEURONTIN (gabapentin) tablet, film coated , NEURONTIN (gabapentin) solution labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[NEURONTIN (gabapentin) capsule , NEURONTIN (gabapentin) tablet, film coated , NEURONTIN (gabapentin) solution labels and packages|Labels and Packages]] | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Gabapentin | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ||
|- | |- | ||
|} | |} |
Latest revision as of 22:58, 12 February 2014
Gabapentin |
---|
NEURONTIN (gabapentin) capsule , NEURONTIN (gabapentin) tablet, film coated , NEURONTIN (gabapentin) solution® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Gabapentin |
ClinicalTrials.gov |